131918-61-1
131918-61-1
Chemical Structure
Paricalcitol
- CAS No.: 131918-61-1
- Formula:C27H44O3
- Molecular Weight:416.64
IUPAC Name: (1R,3R)-5-(2-((1R,3aS,7aR,E)-1-((2R,5S,E)-6-hydroxy-5,6-dimethylhept-3-en-2-yl)-7a-methyloctahydro-4H-inden-4-ylidene)ethylidene)cyclohexane-1,3-diol
InChIKey: BPKAHTKRCLCHEA-UBFJEZKGSA-N
SMILES: C[C@]([C@]([C@H](C)/C=C/[C@H](C)C(C)(C)O)([H])CC1)(CCC/2)[C@]1([H])C2=C\C=C3C[C@@H](O)C[C@H](O)C/3
Biological Activity: Paricalcitol, a vitamin D analogue, is a vitamin D receptor agonist, used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic renal failure.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Paricalcitol | 99.96% | Paricalcitol, a vitamin D analogue, is a vitamin D receptor agonist, used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic renal failure. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Paricalcitol (Standard) | ≥98% | Paricalcitol (Standard) is the analytical standard of Paricalcitol. This product is intended for research and analytical applications. Paricalcitol, a vitamin D analogue, is a vitamin D receptor agonist, used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic renal failure. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Paricalcitol solution | Paricalcitol solution is mainly composed of Paricalcitol (HY-50919). Paricalcitol, a vitamin D analogue, is a vitamin D receptor agonist, used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic renal failure. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Paricalcitol-d6 | 99.85% | Paricalcitol-d6 is the deuterium labeled Paricalcitol. Paricalcitol is a agent used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic renal failure. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
